Literature DB >> 2748449

Treating the patient who has been sexually exploited by a previous therapist.

R P Kluft1.   

Abstract

Patients who have experienced sexual exploitation by a previous therapist constitute an increasingly recognized clinical population. Although some of these patients were transiently overwhelmed or mildly disturbed when exploited, the majority were severely symptomatic and the victims of incest or other previous abuse. Many demonstrate a constellation of four factors that predisposes them to revictimization or the sitting duck syndrome: severe symptoms, idiosyncratic dynamics, atypical socialization that discourages self-care, and cognitive difficulties. The experience of such exploitation is not benign, although the sequelae vary considerably. The treatment of such patients is facilitated by arranging the therapy in a way that maximizes safety and clear communication. The importance of hearing the patient' own reconstructions, pacing the treatment to the patient's tolerance, and respecting the patient's agenda cannot be overemphasized. A cluster of issues that appear central to the treatment of such patients includes addressing their helplessness, their ambivalence about the exploitive therapist, their difficulties with trust, their guilt, their depression and pressures toward self-harm, their confusion over sexuality, their post-traumatic and dissociative features, their severe symptoms and the diagnostic confusion this involves, and the countertransference pressures upon the therapist.

Entities:  

Mesh:

Year:  1989        PMID: 2748449

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  2 in total

1.  All about elephants in rooms and dogs that do not bark in the night: boundary violations and the health professional in India.

Authors:  Sunita Simon Kurpad; Tanya Machado; Ravindra B Galgali; Sheila Daniel
Journal:  Indian J Psychiatry       Date:  2012-01       Impact factor: 1.759

Review 2.  The many faces of dissociation: opportunities for innovative research in psychiatry.

Authors:  Vedat Şar
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-12-26       Impact factor: 2.582

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.